
In a recent interview, Constance Lehman, MD, PhD, discussed newly published research demonstrating the dynamic capability of AI-based risk scores, drawn from screening mammograms, to facilitate risk-adaptive screening.

In a recent interview, Constance Lehman, MD, PhD, discussed newly published research demonstrating the dynamic capability of AI-based risk scores, drawn from screening mammograms, to facilitate risk-adaptive screening.

In a recent episode of our “Molecular Imaging in Focus” series, Surekha Yadav, MBBS, MD, discussed research presented at the SNMMI conference that showed significant advantages of PSMA PET over conventional imaging for detection of osseous oligometastatic prostate cancer (PCa).

The VascularAssist Occlusion Triage software reportedly demonstrated over a 90 percent sensitivity for detecting peripheral artery disease (PAD) on CT in clinical performance testing.

Catch up on the top radiology content of the past week.

In a recent interview, Mary L. Bouxsein, PhD, discussed challenges with access to dual-energy X-ray absorptiometry (DEXA) screening for osteoporosis, the emergence of biomechanical CT (BCT) and the potential impact of national Medicare coverage of BCT for bone mass measurement.

In the latest episode of the Molecular Imaging in Focus series, Michael Hofman, MBBS, FRACP, discussed the potential of an emerging PET radiotracer for DVT detection spotlighted in SNMMI’s “Image of the Year,” a new advance in total body PET/CT and other highlights from the SNMMI conference.

In a recent interview, new SNMMI president Heather Jacene, MD, discussed key goals for bolstering workforce development in nuclear medicine, improving infrastructure equity and optimizing emerging advances to facilitate precision treatments in oncology.

Indicated for the detection and visualization of abnormal vascularity in the central nervous system (CNS) and non-CNS body regions, gadoquatrane provides 60 percent less gadolinium dosing in comparison to other macrocyclic gadolinium (Gd)-based contrast agents (mGBCAs).

Catch up on the top radiology content of the past week.

In a recent interview, Nina Kottler, MD, discussed the challenges with traditional radiology reporting, its impact on cognitive load and the recently launched AI-enabled platform Mosaic Reporting.

In the latest episode of her “Breast Imaging in Focus” series, Manisha Bahl, MD, MPH, FSBI, discusses new research findings from a study involving over 111,000 women that suggest the potential utility of GLP-1 receptor agonists for reducing breast cancer risk.

The AI-enabled image processing with SubtleHD(CT) software reportedly facilitates improved noise reduction and image quality for computed tomography (CT) exams.

In recent interviews, Emanuel Kanal, MD, and Tobias Gilk, MRSO, MRSE, noted a lack of point-of-care safety requirements for MRI, a lack of state oversight, and a prevailing lack of minimum standards overall for MRI safety.

What radiology leaders need to know about the 2026 Medicare Physician Fee Schedule.

David Gruen, MD, MBA, FACR, of Advanced Radiology Consultants, shares how leading programs turned clinical evidence into operational reality.

What's already being done with large language models in radiology practice today.

Catch up on the top radiology content of the past week.

The MIM Contour ProtegeAI+ 2.0 software reportedly offers new AI-powered contouring models for brain MRIs and pelvic CTs.

In comparison to short-axial field of view PET/CT scanners, a total body PET/CT imaging platform with a long axis field of view detected more lesions in 68 percent of patients while reducing scan times by 83 percent, according to new research presented at the SNMMI conference.

In a recent interview, Phillip Kuo, MD, discussed new comparative multicenter prospective research, presented at the SNMMI conference, examining the urinary radioactivity of two PSMA PET radiotracers 18F-piflufolastat and 18F-flotufolastat.

The AI-powered Elevate Plus reportedly facilitates standardization of routine ultrasound, improves scan time and bolsters image quality.

In the latest episode of the Molecular Imaging in Focus series, Isabelle Boileau, PhD, discussed preliminary research, presented at the SNMMI conference, which suggests the utility of a novel tau PET imaging agent that may help detect chronic traumatic encephalopathy (CTE) in living patients.

In a recent interview, Shannon Youngblood, EdD, MSRS, CNMT, RT(CT)(ARRT, shared her perspectives on advocacy for nuclear medicine technologists, scope of practice challenges, theranostics and improving access to PET imaging in rural communities.

Catch up on the top radiology content of the past week.

In a recent interview, Josh Gurewitz and Ajit Shankaranarayanan, PhD, discussed the utility of AI-powered software, including the recently FDA-cleared SubtleHD(PET), for bolstering efficiency and quality with PET imaging.

A randomized controlled trial found that combining Disney characters with soothing ambient elements for pediatric MRI reduced anxiety levels by 43 percent in children under 10 years of age.

The SubtleHD(PET) software reportedly facilitates enhanced image quality, provides improved SUVmax quantitative accuracy and compatibility with all FDA-approved radiotracers.

In recent interviews, Emanuel Kanal, MD, and Tobias Gilk, MRSO, MRSE, discuss new multicenter research examining pediatric MRI safety as well as key challenges and preventive measures in this patient population.

Catch up on the top radiology content of the past week.

In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses current and potential pre-procedure, intra-procedure and post-procedure applications of AI for interventional radiology.